Inhibition of PRMT1 alleviates SI‐AKI by inactivating the transforming growth factor (TGF)‐β1/Smad3 pathway in the cortex and interleukin (IL)‐6/signal transducer and activator of transcription 3 (STAT3) pathway in the medulla. The gene discussed is STAT3; the disease is acute kidney injury.